Unknown

Dataset Information

0

Prognostic Value of Elevated Copeptin and High-Sensitivity Cardiac Troponin T in Patients with and without Acute Coronary Syndrome: The ConTrACS Study.


ABSTRACT: AIMS:We aimed to assess the prognostic role of copeptin in patients presenting to the emergency department with acute symptoms and increased high-sensitivity cardiac troponin T. METHODS:A total of 3890 patients presenting with acute symptoms to the emergency department of Heidelberg University Hospital were assessed for increased hs-cTnT (>14 ng/L) from three cohorts: the Heidelberg Acute Coronary Syndrome (ACS) Registry (n = 2477), the BIOPS Registry (n = 320), and the ACS OMICS Registry (n = 1093). In a pooled analysis, 1956 patients remained, comprising of 1600 patients with ACS and 356 patients with non-ACS. RESULTS:Median follow-up was 1468 days in the ACS cohort and 709 days in the non-ACS cohort. Elevated copeptin levels (>10 pmol/L) were found in 1174 patients (60.0%) in the entire cohort (58.1% in ACS and 68.5% in non-ACS, respectively) and mortality rates were significantly higher than in patients with normal copeptin levels (29.0% vs. 10.7%, p < 0.001). In a multivariate Cox regression, elevated copeptin was independently associated with all-cause death in the ACS (HR = 1.7, 1.3-2.3, p = 0.002) and non-ACS cohort (HR = 2.7, 1.4-5.0, p = 0.0018). CONCLUSION:Copeptin may aid in identifying patients at risk for adverse outcomes in patients with increased levels of hs-cTnT in ACS patients and in non-ACS conditions.

SUBMITTER: Waldsperger H 

PROVIDER: S-EPMC7696893 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic Value of Elevated Copeptin and High-Sensitivity Cardiac Troponin T in Patients with and without Acute Coronary Syndrome: The ConTrACS Study.

Waldsperger Hanna H   Biener Moritz M   Stoyanov Kiril M KM   Vafaie Mehrshad M   Katus Hugo A HA   Giannitsis Evangelos E   Mueller-Hennessen Matthias M  

Journal of clinical medicine 20201111 11


<h4>Aims</h4>We aimed to assess the prognostic role of copeptin in patients presenting to the emergency department with acute symptoms and increased high-sensitivity cardiac troponin T.<h4>Methods</h4>A total of 3890 patients presenting with acute symptoms to the emergency department of Heidelberg University Hospital were assessed for increased hs-cTnT (>14 ng/L) from three cohorts: the Heidelberg Acute Coronary Syndrome (ACS) Registry (<i>n</i> = 2477), the BIOPS Registry (<i>n</i> = 320), and  ...[more]

Similar Datasets

| S-EPMC8200557 | biostudies-literature
| S-EPMC7144484 | biostudies-literature
| S-EPMC6107144 | biostudies-literature
| S-EPMC9267560 | biostudies-literature
| S-EPMC7454979 | biostudies-literature
| S-EPMC7253774 | biostudies-literature
| S-EPMC8379781 | biostudies-literature
| S-EPMC5710293 | biostudies-literature
| S-EPMC6200389 | biostudies-literature
| S-EPMC4320319 | biostudies-literature